Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.57 USD | -3.77% | -5.18% | 0.00% |
15/04 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
15/04 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 413M | |
+2.97% | 108B | |
+10.31% | 105B | |
+1.57% | 23.46B | |
-12.11% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.79% | 17.19B | |
+6.38% | 13.99B | |
+36.86% | 12.53B |
- Stock Market
- Equities
- LENZ Stock
- News LENZ Therapeutics, Inc.
- Piper Sandler Initiates LENZ Therapeutics at Overweight With $28 Price Target